Adamas Pharmaceuticals Inc is a global pharmaceutical company focused on the development and commercialization of superior combination therapeutics.
|
Addex Pharmaceuticals (ADXN: SW) discovers and develops allosteric modulators for human health.
Public
|
Artisan Pharma is dedicated to bringing best-in-class critical-care and hospital-based therapeutics to patients.
|
Codexis (NASDAQ: CDXS) proprietary technology enables cost-effective, efficient and environmentally sound production of pharmaceuticals, transportation fuels, and industrial chemicals.
Public
|
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) is a biopharmaceutical company dedicated to novel, mechanism-targeted drugs to treat human cancers and other serious disorders.
Public
|
Five Prime Therapeutics, Inc. is a clinical stage biotech company discovering innovative protein and antibody therapeutics.
|
FORMA Therapeutics integrates transformative biology and chemistry to unlock targets and pathways that have been validated through genomic medicine as root causes or major drivers of human cancers.
|
Idenix (NASDAQ: IDIX) develops drugs for the treatment of human viral and other infectious disease, focusing is on hepatitis C virus (HCV) and human immunodeficiency virus (HIV).
Public
|
Inviragen is a leading international biotech company focussing on the development of prophylactic vaccines for global emerging infectious diseases with lead programs in dengue virus and EV71 (Hand Foot and Mouth disease).
|
Formerly known as Microbia, Ironwood (NASDAQ: IRWD) pursues clinical candidates with the greatest potential to make a difference in patients' lives.
Public
|
KaloBios Pharmaceuticals uses its biologic capabilities and its proprietary platform technology to develop first-in-class human antibody therapeutics.
|
Kalypsys is a biopharmaceutical company with clinical stage pharmaceutical products.
|
Lonza Biologics Tuas is a joint venture between Bio*One Capital and Lonza Group which established a commercial-scale biologics facility in Singapore.
Acquired
|
Maccine is an established AAALAC-accredited GLP-compliant preclinical CRO providing services including customized translational efficacy model development for various therapeutic areas.
|
MerLion is an anti-infectives focused drug discovery and development company with one of the world's largest and most diverse natural product collections.
|
Perlegen commercializes high-value molecular genetic tests that will significantly improve the clinical decision-making process and ultimately improve patient treatment outcomes.
Acquired
|
Acquired by Evotec AG in 2007, Renovis (NASDAQ:RNVS) develops new drugs for pain and inflammation
Acquired
|
Revance Therapeutics is dedicated to developing the next generation of innovative products in dermatology and aesthetic medicine.
|
S*BIO is an oncology-focused drug discovery and development company with a strong emerging pipeline of drug candidates including two clinical stage programmes in HDAC and JAK-2kinases.
|
Sotera Wireless, Inc. is a San Diego, California, based medical device company dedicated to the development, marketing and sale of a new generation of comprehensive vital signs monitoring. Sotera has developed and clinically tested a new method for measuring cuffless, non-invasive blood pressure (cNIBP). The technology has expanded to become a platform for wireless, body-worn monitoring of all vital signs, ViSi Mobile, bringing ICU-level monitoring to non-ICU clinical settings.
|
Vanda (NASDAQ: VNDX) is working to advance the science of developing new medicines and to use novel approaches to deliver these new medicines to patients.
Public
|